RAnolaZine Efficacy in diabetic patients undergoing Percutaneous Coronary Intervention: beyond its anti-ischemic efficacy (RAZE Trial)
Project Objectives
The aim of our study is to evaluate the possible positive effects of this new drug on endothelial function, platelet aggregation, coagulation activation and glycemic control in patients undergoing coronary revascularization in order to identify potential benefit of ranolazine other than its antianginal actions.
Type of study: prospective, randomized trial
Efficacy end point
Evaluation of endothelial function and platelet reactivity in two groups of treatment.
Secondary end points
Efficacy of ranolazine on metabolic control evaluated by iPRO and HbA1c levels.
Start and End Dates
Not yet started; waiting for Ethical Committee approval
Principal Investigator
- Dr. Annunziata Nusca, Principal Investigator
- Prof. Germano Di Sciascio
Host Institution
Campus Bio-Medico University of Rome